RecruitingNCT02863757
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
Disease Progression and Clinical Outcomes in Chronic Hepatitis B (CHB) Patients With Comorbid Nonalcoholic Fatty Liver Disease (NAFLD)
Sponsor
Humanity and Health Research Centre
Enrollment
1,500 participants
Start Date
Aug 1, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).
Eligibility
Inclusion Criteria3
- Liver biopsy proved CHB and/or NAFLD at baseline;
- Chinese
- Follow-up duration>12 months
Exclusion Criteria6
- Other liver diseases;
- Secondary causes of hepatic steatosis;
- Alcohol abuse;
- Liver cirrhosis, cirrhosis related complications or HCC at baseline;
- Malignancy;
- History of liver transplantation
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02863757
Related Trials
Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
NCT069669083 locations
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
NCT0293215062 locations
VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
NCT060923331 location
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
NCT063649301 location
iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss
NCT072377502 locations